Key facts
- This page summarizes Joan LaRovere's Form 4 filing for LifeMD, Inc. (LFMD).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 08 Oct 2025, 18:03.
Joan LaRovere - 06 Oct 2025 Form 4 Insider Report for LifeMD, Inc. (LFMD)
- Reporting relationship
- Director
- Issuer ticker
- LFMD
- Reported as of
- 06 Oct 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 08 Oct 2025, 18:03:32 UTC
- Prior SEC filing
- 26 Dec 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joan LaRovere
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Joan LaRovere filed Form 4 for LifeMD, Inc. (LFMD) on 08 Oct 2025.
Change
- Previous filing in this sequence was filed on 26 Dec 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001961270
Primary reporting owner
LAROVERE JOAN
- Relationship
- Director
- Address
- C/O LIFEMD, 236 FIFTH AVENUE, SUITE 400, NEW YORK
- Signature
- /s/ Joan LaRovere
- Signature date
- 08 Oct 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LFMD
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +22,365
- Change %
- +26%
- Price
- $0.000000
- Shares after
- 107,050
- Date
- 06 Oct 2025
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The grant of restricted shares vests on June 1, 2026.